{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:47:02Z","timestamp":1784040422824,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H29-Policy-Designated-009"],"award-info":[{"award-number":["H29-Policy-Designated-009"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H29-ICT-General-004"],"award-info":[{"award-number":["H29-ICT-General-004"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"the Ministry of Education, Culture, Sports, Science and Technology, Japan","doi-asserted-by":"crossref","award":["17H04141"],"award-info":[{"award-number":["17H04141"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s40257-019-00443-9","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T18:44:18Z","timestamp":1556649858000},"page":"579-592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Association of Early Systemic Corticosteroid Therapy with Mortality in Patients with Stevens\u2013Johnson Syndrome or Toxic Epidermal Necrolysis: A Retrospective Cohort Study Using a Nationwide Claims Database"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2306-0669","authenticated-orcid":false,"given":"Kojiro","family":"Morita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Michihata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"issue":"6","key":"443_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1586\/eci.11.66","volume":"7","author":"M Mockenhaupt","year":"2011","unstructured":"Mockenhaupt M. The current understanding of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol. 2011;7(6):803\u201313. \n                    https:\/\/doi.org\/10.1586\/eci.11.66\n                    \n                  \n                           (quiz 14\u20135).","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"443_CR2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","volume":"138","author":"A Auquier-Dunant","year":"2002","unstructured":"Auquier-Dunant A, Mockenhaupt M, Naldi L, et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens\u2013Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002;138(8):1019\u201324.","journal-title":"Arch Dermatol"},{"issue":"19","key":"443_CR3","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","volume":"331","author":"JC Roujeau","year":"1994","unstructured":"Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994;331(19):1272\u201385. \n                    https:\/\/doi.org\/10.1056\/NEJM199411103311906\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"7","key":"443_CR4","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.burns.2014.02.006","volume":"40","author":"PD Mahar","year":"2014","unstructured":"Mahar PD, Wasiak J, Hii B, et al. A systematic review of the management and outcome of toxic epidermal necrolysis treated in burns centres. Burns. 2014;40(7):1245\u201354. \n                    https:\/\/doi.org\/10.1016\/j.burns.2014.02.006\n                    \n                  .","journal-title":"Burns"},{"issue":"3","key":"443_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40264-015-0390-9","volume":"39","author":"RP Dodiuk-Gad","year":"2016","unstructured":"Dodiuk-Gad RP, Olteanu C, Chung WH, Shear NH. The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015. Drug Saf. 2016;39(3):271\u20136. \n                    https:\/\/doi.org\/10.1007\/s40264-015-0390-9\n                    \n                  .","journal-title":"Drug Saf"},{"issue":"5","key":"443_CR6","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.jaad.2015.08.008","volume":"73","author":"RP Dodiuk-Gad","year":"2015","unstructured":"Dodiuk-Gad RP, Olteanu C, Jeschke MG, Cartotto R, Fish J, Shear NH. Treatment of toxic epidermal necrolysis in North America. J Am Acad Dermatol. 2015;73(5):876\u2013877.e2. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2015.08.008\n                    \n                  .","journal-title":"J Am Acad Dermatol"},{"issue":"9140","key":"443_CR7","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/s0140-6736(98)02197-7","volume":"352","author":"P Wolkenstein","year":"1998","unstructured":"Wolkenstein P, Latarjet J, Roujeau J-C, et al. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet. 1998;352(9140):1586\u20139. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(98)02197-7\n                    \n                  .","journal-title":"Lancet"},{"issue":"3","key":"443_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/2042098611404094","volume":"2","author":"JC Roujeau","year":"2011","unstructured":"Roujeau JC, Bastuji-Garin S. Systematic review of treatments for Stevens\u2013Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality. Ther Adv Drug Saf. 2011;2(3):87\u201394. \n                    https:\/\/doi.org\/10.1177\/2042098611404094\n                    \n                  .","journal-title":"Ther Adv Drug Saf"},{"issue":"3","key":"443_CR9","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1172\/JCI93349","volume":"128","author":"CW Wang","year":"2018","unstructured":"Wang CW, Yang LY, Chen CB, et al. Randomized, controlled trial of TNF-alpha antagonist in CTL-mediated severe cutaneous adverse reactions. J Clin Investig. 2018;128(3):985\u201396. \n                    https:\/\/doi.org\/10.1172\/JCI93349\n                    \n                  .","journal-title":"J Clin Investig"},{"issue":"2","key":"443_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1365-2133.2005.06721.x","volume":"153","author":"TA Chave","year":"2005","unstructured":"Chave TA, Mortimer NJ, Sladden MJ, Hall AP, Hutchinson PE. Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol. 2005;153(2):241\u201353. \n                    https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06721.x\n                    \n                  .","journal-title":"Br J Dermatol"},{"issue":"12","key":"443_CR11","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/ijd.13379","volume":"55","author":"W Liu","year":"2016","unstructured":"Liu W, Nie X, Zhang L. A retrospective analysis of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis treated with corticosteroids. Int J Dermatol. 2016;55(12):1408\u201313. \n                    https:\/\/doi.org\/10.1111\/ijd.13379\n                    \n                  .","journal-title":"Int J Dermatol"},{"key":"443_CR12","doi-asserted-by":"publisher","first-page":"237821","DOI":"10.1155\/2014\/237821","volume":"2014","author":"W Roongpisuthipong","year":"2014","unstructured":"Roongpisuthipong W, Prompongsa S, Klangjareonchai T. Retrospective analysis of corticosteroid treatment in Stevens\u2013Johnson syndrome and\/or toxic epidermal necrolysis over a period of 10\u00a0years in Vajira Hospital, Navamindradhiraj University, Bangkok. Dermatol Res Pract. 2014;2014:237821. \n                    https:\/\/doi.org\/10.1155\/2014\/237821\n                    \n                  .","journal-title":"Dermatol Res Pract"},{"issue":"1","key":"443_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","volume":"58","author":"J Schneck","year":"2008","unstructured":"Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M. Effects of treatments on the mortality of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol. 2008;58(1):33\u201340. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2007.08.039\n                    \n                  .","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"443_CR14","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/jid.2012.510","volume":"133","author":"P Sekula","year":"2013","unstructured":"Sekula P, Dunant A, Mockenhaupt M, et al. Comprehensive survival analysis of a cohort of patients with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. J Investig Dermatol. 2013;133(5):1197\u2013204. \n                    https:\/\/doi.org\/10.1038\/jid.2012.510\n                    \n                  .","journal-title":"J Investig Dermatol"},{"issue":"10","key":"443_CR15","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1365-4632.2009.04166.x","volume":"48","author":"Y Yang","year":"2009","unstructured":"Yang Y, Xu J, Li F, Zhu X. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens\u2013Johnson syndrome: a retrospective comparative study in China. Int J Dermatol. 2009;48(10):1122\u20138. \n                    https:\/\/doi.org\/10.1111\/j.1365-4632.2009.04166.x\n                    \n                  .","journal-title":"Int J Dermatol"},{"issue":"3","key":"443_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00004630-200021030-00004","volume":"21","author":"JT Schulz","year":"2000","unstructured":"Schulz JT, Sheridan RL, Ryan CM, MacKool B, Tompkins RG. A 10-year experience with toxic epidermal necrolysis. J Burn Care Rehabil. 2000;21(3):199\u2013204.","journal-title":"J Burn Care Rehabil"},{"issue":"1","key":"443_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/PRS.0b013e3181773d5d","volume":"122","author":"AH Dorafshar","year":"2008","unstructured":"Dorafshar AH, Dickie SR, Cohn AB, et al. Antishear therapy for toxic epidermal necrolysis: an alternative treatment approach. Plast Reconstr Surg. 2008;122(1):154\u201360. \n                    https:\/\/doi.org\/10.1097\/PRS.0b013e3181773d5d\n                    \n                  .","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"443_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/00015550510038232","volume":"85","author":"KJ Kim","year":"2005","unstructured":"Kim KJ, Lee DP, Suh HS, et al. Toxic epidermal necrolysis: analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients. Acta Derm Venereol. 2005;85(6):497\u2013502. \n                    https:\/\/doi.org\/10.1080\/00015550510038232\n                    \n                  .","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"443_CR19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamadermatol.2016.5668","volume":"153","author":"S Zimmermann","year":"2017","unstructured":"Zimmermann S, Sekula P, Venhoff M, et al. Systemic immunomodulating therapies for Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol. 2017;153(6):514\u201322. \n                    https:\/\/doi.org\/10.1001\/jamadermatol.2016.5668\n                    \n                  .","journal-title":"JAMA Dermatol"},{"issue":"4","key":"443_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/01.iio.0000177430.89645.6d","volume":"45","author":"AY Hynes","year":"2005","unstructured":"Hynes AY, Kafkala C, Daoud YJ, Foster CS. Controversy in the use of high-dose systemic steroids in the acute care of patients with Stevens\u2013Johnson syndrome. Int Ophthalmol Clin. 2005;45(4):25\u201348.","journal-title":"Int Ophthalmol Clin"},{"issue":"6","key":"443_CR21","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/bjd.14530","volume":"174","author":"D Creamer","year":"2016","unstructured":"Creamer D, Walsh SA, Dziewulski P, et al. U.K. guidelines for the management of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis in adults 2016. Br J Dermatol. 2016;174(6):1194\u2013227. \n                    https:\/\/doi.org\/10.1111\/bjd.14530\n                    \n                  .","journal-title":"Br J Dermatol"},{"issue":"1","key":"443_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.alit.2016.06.001","volume":"66","author":"Y Kinoshita","year":"2017","unstructured":"Kinoshita Y, Saeki H. A review of toxic epidermal necrolysis management in Japan. Allergol Int. 2017;66(1):36\u201341. \n                    https:\/\/doi.org\/10.1016\/j.alit.2016.06.001\n                    \n                  .","journal-title":"Allergol Int"},{"issue":"9","key":"443_CR23","first-page":"1637","volume":"126","author":"The Japanese Guideline Committee on Erythema Multiforme Major","year":"2016","unstructured":"The Japanese Guideline Committee on Erythema Multiforme Major. Guidelines for the management of Stevens\u2013Johnson syndrome and toxic epidermal necrosis. Jpn J Dermatol. 2016;126(9):1637\u201385 (in Japanese).","journal-title":"Jpn J Dermatol"},{"issue":"4","key":"443_CR24","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/aje\/kwm324","volume":"167","author":"S Suissa","year":"2008","unstructured":"Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol. 2008;167(4):492\u20139. \n                    https:\/\/doi.org\/10.1093\/aje\/kwm324\n                    \n                  .","journal-title":"Am J Epidemiol"},{"issue":"11","key":"443_CR25","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1177\/0091270003258651","volume":"43","author":"DE Mager","year":"2003","unstructured":"Mager DE, Lin SX, Blum RA, Lates CD, Jusko WJ. Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics. J Clin Pharmacol. 2003;43(11):1216\u201327. \n                    https:\/\/doi.org\/10.1177\/0091270003258651\n                    \n                  .","journal-title":"J Clin Pharmacol"},{"issue":"28","key":"443_CR26","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661\u201379. \n                    https:\/\/doi.org\/10.1002\/sim.6607\n                    \n                  .","journal-title":"Stat Med"},{"issue":"20","key":"443_CR27","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1002\/sim.3854","volume":"29","author":"PC Austin","year":"2010","unstructured":"Austin PC. The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies. Stat Med. 2010;29(20):2137\u201348. \n                    https:\/\/doi.org\/10.1002\/sim.3854\n                    \n                  .","journal-title":"Stat Med"},{"issue":"5","key":"443_CR28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","volume":"11","author":"MA Hernan","year":"2000","unstructured":"Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000;11(5):561\u201370.","journal-title":"Epidemiology"},{"issue":"11","key":"443_CR29","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1111\/ijd.12118","volume":"53","author":"P Su","year":"2014","unstructured":"Su P, Aw CWD. Severe cutaneous adverse reactions in a local hospital setting: a 5-year retrospective study. Int J Dermatol. 2014;53(11):1339\u201345. \n                    https:\/\/doi.org\/10.1111\/ijd.12118\n                    \n                  .","journal-title":"Int J Dermatol"},{"issue":"6","key":"443_CR30","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.ajo.2008.12.040","volume":"147","author":"Y Araki","year":"2009","unstructured":"Araki Y, Sotozono C, Inatomi T, et al. Successful treatment of Stevens\u2013Johnson syndrome with steroid pulse therapy at disease onset. Am J Ophthalmol. 2009;147(6):1004\u20131011.e1. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2008.12.040\n                    \n                  .","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"443_CR31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2340\/00015555-0214","volume":"87","author":"SH Kardaun","year":"2007","unstructured":"Kardaun SH, Jonkman MF. Dexamethasone pulse therapy for Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis. Acta Derm Venereol. 2007;87(2):144\u20138. \n                    https:\/\/doi.org\/10.2340\/00015555-0214\n                    \n                  .","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"443_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","volume":"115","author":"S Bastuji-Garin","year":"2000","unstructured":"Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Investig Dermatol. 2000; 115(2):149\u201353. \n                    https:\/\/doi.org\/10.1046\/j.1523-1747.2000.00061.x\n                    \n                  .","journal-title":"J Investig Dermatol"},{"issue":"1","key":"443_CR33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens\u2013Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129(1):92\u20136.","journal-title":"Arch Dermatol"},{"issue":"10","key":"443_CR34","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.je.2016.09.009","volume":"27","author":"H Yamana","year":"2017","unstructured":"Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol. 2017;27(10):476\u201382. \n                    https:\/\/doi.org\/10.1016\/j.je.2016.09.009\n                    \n                  .","journal-title":"J Epidemiol"},{"issue":"4","key":"443_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2332\/allergolint.O-07-483","volume":"56","author":"Y Yamane","year":"2007","unstructured":"Yamane Y, Aihara M, Ikezawa Z. Analysis of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006. Allergol Int. 2007;56(4):419\u201325. \n                    https:\/\/doi.org\/10.2332\/allergolint.O-07-483\n                    \n                  .","journal-title":"Allergol Int"},{"issue":"1","key":"443_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.alit.2015.09.001","volume":"65","author":"Y Yamane","year":"2016","unstructured":"Yamane Y, Matsukura S, Watanabe Y, et al. Retrospective analysis of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients\u2014treatment and outcome. Allergol Int. 2016;65(1):74\u201381. \n                    https:\/\/doi.org\/10.1016\/j.alit.2015.09.001\n                    \n                  .","journal-title":"Allergol Int"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-019-00443-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-019-00443-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-019-00443-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T22:50:21Z","timestamp":1589669421000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-019-00443-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,30]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["443"],"URL":"https:\/\/doi.org\/10.1007\/s40257-019-00443-9","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,30]]},"assertion":[{"value":"30 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Kojiro Morita, Hiroki Matsui, Nobuaki Michihata, Kiyohide Fushimi, and Hideo Yasunaga declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This work was supported by grants from the Ministry of Health, Labour and Welfare, Japan (H29-Policy-Designated-009 and H29-ICT-General-004); the Ministry of Education, Culture, Sports, Science and Technology, Japan (17H04141); and the Japan Agency for Medical Research and Development (AMED). The funding source had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"This study was approved by the Institutional Review Board of The University of Tokyo.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The requirement for informed patient consent was waived because of the anonymous nature of the data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}